Kezar Life Sciences

FDA places hold on Kezar Life Sciences’ trial for lupus nephritis treatment
Clinical Trials Arena
Mon, 10/7/24 - 11:29 am
Kezar Life Sciences
lupus nephritis
FDA
zetomipzomib
clinical trials
Kezar Life Sciences pauses trial for lupus treatment after patient deaths
Reuters
Mon, 09/30/24 - 08:34 pm
Kezar Life Sciences
lupus
clinical trials
patient deaths
Kezar stalls solid tumor trial to focus on autoimmune disease candidate
Pharmaceutical Technology
Wed, 08/14/24 - 11:05 am
Kezar Life Sciences
zetomipzomib
clinical trials
lupus
autoimmune hepatitis
solid tumors
Kezar to commence Phase IIa autoimmune hepatitis therapy trial
Clinical Trials Arena
Tue, 10/4/22 - 10:36 am
Kezar Life Sciences
clinical trials
zetomipzomib
autoimmune hepatitis
Amgen spinout Kezar hits PhII hurdle, all eyes on June readout for drug’s other study
Endpoints
Wed, 05/4/22 - 10:39 am
Amgen
Kezar Life Sciences
zetomipzomib
autoimmune disease
dermatomyositis
polymyositis
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours
Xconomy
Thu, 06/21/18 - 12:04 pm
biotech
IPOs
Eidos Therapeutics
Avrobio
XERIS
Aptinyx
Kezar Life Sciences
Magenta Therapeutics